Biotech company Neuren Pharmaceuticals has said projected global sales of its Rett syndrome treatment Daybue are set to reach ...

Eric Lipar, Chairman & CEO, opened by emphasizing the company's focus on "driving leads, managing inventory and supporting our customers by delivering exceptional customer service and providing a ...